| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/19/2011 | CA2459165C Dosage forms having prolonged active ingredient release |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/19/2011 | CA2341441C Methods of using and compositions comprising dopamine reuptake inhibitors |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/14/2011 | WO2011085201A1 Fumagillol type compounds and methods of making and using same |
| 07/14/2011 | WO2011084901A2 A nutritional supplement to improve supplementary target protein fraction (tpf) delivery, intracellular absorption and utilization |
| 07/14/2011 | WO2011084459A1 Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases |
| 07/14/2011 | WO2011084456A1 Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases |
| 07/14/2011 | WO2011084453A1 Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases |
| 07/14/2011 | WO2011084046A1 Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atherosclerosis and cardiovascular disease |
| 07/14/2011 | WO2011083999A2 Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient |
| 07/14/2011 | WO2011083998A2 Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient |
| 07/14/2011 | WO2011083804A1 Indole derivative |
| 07/14/2011 | WO2011083150A2 Obesity small molecules |
| 07/14/2011 | WO2011082458A1 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with these diseases, such as cachexia, and remedying adverse effects of drugs and treatments, such as immunodepression, neutropenia and lymphocytopenia, comprising the association or combination of a specially selected biological response modifier and other antineoplastic compounds and/or other treatments |
| 07/14/2011 | WO2011031111A3 Alkoxy indole-3-acetic acid derivative acting as ppar α/γ/δ agonists, preparation method thereof, and pharmaceutical composition containing same as active ingredient |
| 07/14/2011 | WO2011028813A3 Insulin analogues of enhanced receptor-binding specificity |
| 07/14/2011 | WO2010144140A4 Egfr and par2 regulation of intestinal permeability |
| 07/14/2011 | WO2008118850A3 Dietary compositions |
| 07/14/2011 | US20110173722 Novel insulin derivatives having an extremely delayed time-action profile |
| 07/14/2011 | US20110173711 eNos Mutations Useful for Gene Therapy and Therapeutic Screening |
| 07/14/2011 | US20110173707 System for the Determination of Molecules Altering the Function of Interferon, Method Therefor and Compounds Altering Interferon Activity |
| 07/14/2011 | US20110172434 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 07/14/2011 | US20110172312 Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones |
| 07/14/2011 | US20110172306 Creatine ester pronutrient compounds and formulations |
| 07/14/2011 | US20110172305 Endocannabinoids for Enhancing Growth and Development in Infants |
| 07/14/2011 | US20110172300 Novel epigallocatechin gallate trimer and alpha-glucosidase inhibitor containing epigallocatechin gallate polymer |
| 07/14/2011 | US20110172292 Antidote oligomers |
| 07/14/2011 | US20110172289 Minor groove binder (mgb)-oligonucleotide mirna antagonists |
| 07/14/2011 | US20110172283 Tricyclic Indeno-Pyrrole Derivatives as Serotonin Receptor Modulators |
| 07/14/2011 | US20110172278 Compounds and methods for modulating g protein-coupled receptors |
| 07/14/2011 | US20110172274 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity |
| 07/14/2011 | US20110172270 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 07/14/2011 | US20110172266 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/14/2011 | US20110172265 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 07/14/2011 | US20110172263 Indole derivatives as crth2 receptor antagonists |
| 07/14/2011 | US20110172260 Methods of providing weight loss therapy in patients with major depression |
| 07/14/2011 | US20110172256 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 07/14/2011 | US20110172246 1-(2-phenoxymethylphenyl)piperazine compounds |
| 07/14/2011 | US20110172244 Compounds and compositions as modulators of gpr119 activity |
| 07/14/2011 | US20110172239 Compounds, Compositions and Methods for the Treatment of Amyloid Diseases and Synucleinopathies such as Alzheimer's Disease, Type 2 Diabetes and Parkinson's Disease |
| 07/14/2011 | US20110172235 Substituted triazolophthalazine derivatives |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172229 Modulators of atp-binding cassette transporters |
| 07/14/2011 | US20110172228 Kinase inhibitors and methods of use |
| 07/14/2011 | US20110172219 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| 07/14/2011 | US20110172216 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use |
| 07/14/2011 | US20110172209 3h-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of gpr81 receptor disorders |
| 07/14/2011 | US20110172204 Compounds and their use |
| 07/14/2011 | US20110172198 TGR5 Modulators And Methods Of Use Thereof |
| 07/14/2011 | US20110172190 Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
| 07/14/2011 | US20110172176 Crystal structures of sglt2 inhibitors and processes for preparing same |
| 07/14/2011 | US20110172160 Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 07/14/2011 | US20110172153 Screening methods using g-protein coupled receptors and related compositions |
| 07/14/2011 | US20110172149 Method of Regulating Glucose Metabolism, and Reagents Related Thereto |
| 07/14/2011 | US20110172148 Periostin-induced pancreatic regeneration |
| 07/14/2011 | US20110172147 Neuropeptide-2 receptor (y-2r) agonists |
| 07/14/2011 | US20110172146 Growth hormone polypeptides and methods of making and using same |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171328 Pharmaceutical composition for treating diabetes |
| 07/14/2011 | US20110171317 Method for inhibiting accumulation of visceral fat |
| 07/14/2011 | US20110171312 Modified therapeutic peptides, methods of their preparation and use |
| 07/14/2011 | US20110171283 Composition containing at least one nutrivite, at least one disinfecting or decontaminating, and/or at least one protease-inhibiting active compound and/or active compound complex |
| 07/14/2011 | US20110171276 Non-Viral Compositions and Methods for Transfecting Gut Cells In Vivo |
| 07/14/2011 | US20110171275 Gastroretentive drug delivery system, preparation method and use thereof |
| 07/14/2011 | US20110171270 Novel solid state forms of laquinimod and its sodium salt |
| 07/14/2011 | US20110171268 Uricase compositions and methods of use |
| 07/14/2011 | US20110171265 Composition Comprising Parasite Eggs and Methods for Isolation and Storage of Parasite Eggs |
| 07/14/2011 | US20110171246 Nutritional Supplement to improve supplementary target protein fraction (TPF) delivery, intracellular absorption and utilization |
| 07/14/2011 | US20110171220 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171207 Compositions and methods for treating inflammation and auto-immune diseases |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171201 Formulation for Oral Administration of Proteins |
| 07/14/2011 | US20110171198 Highly functional enzyme having alpha-galactosidase activity |
| 07/14/2011 | US20110171197 Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same |
| 07/14/2011 | US20110171195 Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp |
| 07/14/2011 | US20110171192 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 07/14/2011 | US20110171191 Suppression of neuroendocrine diseases |
| 07/14/2011 | US20110171187 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints |
| 07/14/2011 | US20110171178 Compositions and methods of using proislet peptides and analogs thereof |
| 07/14/2011 | US20110171166 Polymer conjugates of osteocalcin peptides |
| 07/14/2011 | US20110171159 Glycoside Derivatives and Uses Thereof |
| 07/14/2011 | US20110171142 Metformin glycinate salt for blood glucose control |
| 07/14/2011 | US20110171136 Optical imaging probes |
| 07/14/2011 | US20110171128 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 07/14/2011 | CA2786777A1 Obesity small molecules |
| 07/14/2011 | CA2786603A1 Fumagillol type compounds and methods of making and using same |
| 07/14/2011 | CA2783468A1 Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases |
| 07/14/2011 | CA2783264A1 Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases |
| 07/14/2011 | CA2783262A1 Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343314A2 Calcium fluoride phosphopeptide complexes |
| 07/13/2011 | EP2343279A1 Fused-ring derivative and medical application of same |
| 07/13/2011 | EP2343082A1 Oxyntomodulin for preventing or treating excess weight |
| 07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 07/13/2011 | EP2343065A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 07/13/2011 | EP2343062A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 07/13/2011 | EP2342979A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342977A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342976A2 Composition for improving membrane composition and functioning of cells |